Hunan Fangsheng Pharmaceutical Co., Ltd. (SHA:603998)

Market Cap	4.62B
Revenue (ttm)	1.76B
Net Income (ttm)	272.96M
Shares Out	439.08M
EPS (ttm)	0.61
PE Ratio	17.40
Forward PE	14.83
Dividend	0.25 (2.37%)
Ex-Dividend Date	Mar 5, 2025

Volume	42,848,499
Average Volume	13,116,404
Open	9.88
Previous Close	9.92
Day's Range	9.87 - 10.60
52-Week Range	8.47 - 13.58
Beta	0.30
RSI	66.92
Earnings Date	Aug 29, 2025

About SHA:603998

Hunan Fangsheng Pharmaceutical Co., Ltd. researches, develops, produces, and sells pharmaceutical products in China. It offers medicines in the form of tablets, capsules, and granules for the treatment of orthopedic, cardiovascular and cerebrovascular, anti-infection, pediatric, gynecological, respiratory system, traumatology, and other diseases. The company was founded in 2002 and is based in Changsha, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2002
• Employees: 1,686
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 603998

Financial Performance

In 2023, SHA:603998's revenue was 1.63 billion, a decrease of -9.12% compared to the previous year's 1.79 billion. Earnings were 186.82 million, a decrease of -34.64%.